Free Trial

Annovis Bio (ANVS) SEC Filings & 10K Form

Annovis Bio logo
$6.60 +0.06 (+0.92%)
(As of 11:20 AM ET)

Recent Annovis Bio SEC Filings

DateFilerForm TypeView
11/08/2024
4:08 PM
Annovis Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/15/2024
7:12 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
7:38 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
6:15 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2024
7:05 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
3:05 PM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
4:15 PM
Annovis Bio (Issuer)
Bruck Claudine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
4:16 PM
Annovis Bio (Issuer)
Hoffman Michael B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
4:16 PM
Annovis Bio (Issuer)
Maccecchini Maria-Luisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
4:17 PM
Annovis Bio (Issuer)
McCarthy Reid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
4:18 PM
Annovis Bio (Issuer)
White Mark K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
7:14 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
4:15 PM
Annovis Bio (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/13/2024
5:05 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
3:32 PM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
4:11 PM
Annovis Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2024
4:18 PM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
3:50 PM
Annovis Bio (Filer)
Form 424B5
04/29/2024
4:14 PM
Annovis Bio (Filer)
Form ARS
04/26/2024
7:14 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
4:12 PM
Annovis Bio (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/22/2024
4:24 PM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2024
4:23 PM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
3:43 PM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
8:20 PM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
9:00 PM
Annovis Bio (Filer)
Form 424B5
03/15/2024
4:22 PM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
11:15 PM
Annovis Bio (Filer)
Form EFFECT
11/22/2023
3:23 PM
Annovis Bio (Issuer)
Maccecchini Maria-Luisa (Reporting)
Form 4/A
11/22/2023
3:24 PM
Annovis Bio (Issuer)
Hoffman Michael B (Reporting)
Form 4/A
11/22/2023
3:24 PM
Annovis Bio (Issuer)
McCarthy Reid (Reporting)
Form 4/A
11/22/2023
3:27 PM
Annovis Bio (Issuer)
White Mark K. (Reporting)
Form 4/A
11/22/2023
3:14 PM
Annovis Bio (Issuer)
Bruck Claudine (Reporting)
Form 4/A
11/22/2023
3:21 PM
Annovis Bio (Issuer)
Hagopian Henry III (Reporting)
Form 4/A
11/21/2023
1:31 PM
Annovis Bio (Issuer)
White Mark K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
1:32 PM
Annovis Bio (Issuer)
Hoffman Michael B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
1:33 PM
Annovis Bio (Issuer)
McCarthy Reid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
1:27 PM
Annovis Bio (Issuer)
Bruck Claudine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
1:29 PM
Annovis Bio (Issuer)
Hagopian Henry III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
1:30 PM
Annovis Bio (Issuer)
Maccecchini Maria-Luisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:ANVS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners